Ambalal Sarabhai Enterprises Ltd Share Price Live
Live Ambalal Sarabhai Enterprises Share Price Chart
Ambalal Sarabhai Enterprises Performance
Days Range
| Previous Close | ₹28.96 |
|---|---|
| Open | ₹29.3 |
| Volume | 71,893 |
| Day's Range | ₹28.35 - ₹29.30 |
|---|---|
| 52W Range | ₹28.35 - ₹68.00 |
| Market Cap | ₹221.93 Cr |
Ambalal Sarabhai Enterprises Fundamentals
| ROCE(TTM) | 10.22 |
|---|---|
| P/E Ratio (TTM) | 22.98 |
| P/B Ratio | 1.5 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.32 |
| ROE | 10.60 |
| EPS (TTM) | 2.04 |
| Dividend Yield | 0 |
| Book Value | 19.25 |
| Face Value | 10 |
| ROCE(TTM) | 10.22 |
|---|---|
| P/E Ratio (TTM) | 22.98 |
| P/B Ratio | 1.5 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.32 |
| ROE | 10.60 |
|---|---|
| EPS (TTM) | 2.04 |
| Dividend Yield | 0 |
| Book Value | 19.25 |
| Face Value | 10 |
Ambalal Sarabhai Enterprises Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 45.97 | 64.81 | 40.34 | 44.45 |
| Expenses | 47.66 | 60.43 | 39.74 | 45.00 |
| Profit before tax | 2.93 | -2.05 | 7.93 | -0.04 |
| Operating Profit | 2.23 | -0.27 | 8.22 | -0.56 |
| Net Profit | 2.23 | -0.27 | 8.22 | -0.56 |
| ESP in Rs | 0.29 | 1.77 | 1.07 | -0.07 |
Ambalal Sarabhai Enterprises Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 31.35% | 31.35% | 31.35% | 31.35% | 31.35% |
| Flls | 0% | 0% | 0.38% | 0.38% | 0.34% |
| Dlls | 0.01% | 0.1% | 0.1% | 0.01% | 0.01% |
| Public | 68.65% | 68.55% | 68.17% | 68.27% | 68.31% |
About Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. The company operates in two segments, namely pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd, Haryana Containers Ltd, Asence Inc, Asence Pharma Pvt Ltd, Mautik Exim Ltd, Systronics ( I ) Ltd, Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd.
Ambalal Sarabhai Enterprises Ltd was incorporated on June 5, 1978. The company became a public limited company in December 1980. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections.
During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India.
During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The product division essentially comprising of Sarabai Chemicals products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd.
In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd.
During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system.
During the year 2010-11, the company has transferred and assigned as a going concern the undertaking and business of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and electronics division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.
Parent Organisation
Sarabhai Ent
Managing Director
Kartikeya V Sarabhai
Founded
1977
NSE Symbol
AMBASARABH
Top Mutual Funds Invested in Ambalal Sarabhai Enterprises Share
Top Mutual Funds Invested in Ambalal Sarabhai Enterprises Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,831.1 20.80 (1.15%) | ₹4,34,159.66 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,471.0 -19.50 (-0.30%) | ₹1,72,287.78 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 3,722.0 -8.40 (-0.23%) | ₹1,26,434.15 | 2,886.45 - 3,882.2 |
| Cipla Ltd | 1,530.9 5.70 (0.37%) | ₹1,23,148.76 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,257.1 7.80 (0.62%) | ₹1,04,369.38 | 1,020.0 - 1,405.9 |
| Lupin Ltd | 2,085.1 13.70 (0.66%) | ₹94,659.39 | 1,795.2 - 2,402.9 |
Popular stocks
Ambalal Sarabhai Enterprises Ltd FAQs
What is the share price of Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares?
Ambalal Sarabhai Enterprises Ltd (AMBASARABH) share price as of November 28, 2025, on NSE is Rs 28.4 (NSE) and Rs 28.4 (BSE) on BSE.
Can I buy Ambalal Sarabhai Enterprises Ltd (AMBASARABH) from Angel One?
Yes, You can buy Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares by opening a Demat account with Angel One.
How do I buy Ambalal Sarabhai Enterprises Ltd (AMBASARABH) from Angel One?
Ambalal Sarabhai Enterprises Ltd (AMBASARABH) share can be bought through the following modes:
1. Direct investment: You can buy Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares.
1. Direct investment: You can buy Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ambalal Sarabhai Enterprises Ltd (AMBASARABH) shares.
